GoKawiilExin Therapeutics AI agent performs brain injection on live mouse
Exin Therapeutics CEO Gabriel Ocana Santero built a surgical rig linking an AI agent to a motorized mouse restraint, camera, and injection needle, letting the AI control a brain injection procedure on a live mouse. The team used the setup to test a gene therapy aimed at reducing seizures in a mouse with epilepsy, with the agent directing needle placement and compound delivery rather than just analyzing data.
GoKawiil's interpretation of the reporting above, not reported fact.
The experiment suggests AI agents could move beyond designing or interpreting experiments to actively performing physical lab procedures, which Santero argues would expose models to real-world variables like failed attempts and unexpected observations that published literature omits. If such agent-controlled lab work scales, it could reshape how biotech research is conducted, though this remains an early, single demonstration rather than proof of reliability at scale.
- An AI agent directed a robotic rig to inject a compound into a live mouse's brain.
- The test, led by Exin Therapeutics' Gabriel Ocana Santero, involved a gene therapy aimed at reducing epileptic seizures.
- Santero says connecting AI agents directly to lab equipment could improve model reliability by exposing them to real experimental conditions.
Source: wired.com — Emily Mullin, 2026-10-31
Published there as: “An AI Agent Injected Drugs Into a Live Mouse’s Brain”
Read the original report → The summary and analysis above are GoKawiil's own, written from reporting by the source above. Facts and quotes belong to the original publisher.